Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Tourmaline Bio, Inc. | CEO, Director | Common Stock | 7K | $104K | $14.85 | Aug 21, 2024 | By Gilead Capital, LP |
Tourmaline Bio, Inc. | CEO, Director | Employee Stock Option (Right to Buy) | 254K | Oct 23, 2023 | Direct | ||
Zura Bio Ltd | Director | Employee Share Option (Right to Buy) | 208K | May 18, 2023 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
TRML | Tourmaline Bio, Inc. | Aug 21, 2024 | 1 | $26.4K | 4 | Aug 22, 2024 | CEO, Director |
TRML | Tourmaline Bio, Inc. | Aug 16, 2024 | 1 | $72K | 4 | Aug 20, 2024 | CEO, Director |
TRML | Tourmaline Bio, Inc. | Nov 17, 2023 | 1 | $68K | 4 | Nov 20, 2023 | CEO, Director |
TALS | Tourmaline Bio, Inc. | Oct 24, 2023 | 2 | $111K | 4 | Oct 26, 2023 | CEO, Director |
TALS | Tourmaline Bio, Inc. | Oct 19, 2023 | 3 | $0 | 4 | Oct 23, 2023 | CEO, Director |
TALS | Tourmaline Bio, Inc. | Oct 19, 2023 | 0 | $0 | 3 | Oct 23, 2023 | CEO, Director |
ZURA | Zura Bio Ltd | May 18, 2023 | 1 | $0 | 4 | May 22, 2023 | Director |
ZURA | Zura Bio Ltd | Mar 20, 2023 | 0 | $0 | 3 | Mar 21, 2023 | Director |